One of the things discussed in this article is a fairly common complaint that my wife, a physician, brings home from work. The lack of diversity and patient pa

One of the things discussed in this article is a fairly common complaint that my wife, a physician, brings home from work. The lack of diversity and patient panels affects all kinds of drug research - not just pain medicine. And panels are not just unbalanced on the basis of sex - but basically everything. Patient panels are largely made up of white middle-class men. Anything that might vary on sex, ethnicity, economics, or access to care, is largely overlooked by these skewed panels. (Admittedly this is slowly getting better - but standard practice is based on old studies, and skewed panels). This leads to frustration knowing that things are broken - but having little clue as to what the best practice would be as they don't have enough data....